|
Market Cap (25-Jun) $4,172,944 (725th) |
Close (30-Jun) $0.260 |
Volume (30-Jun) 239,872 |
Shortsold (5-Oct) 64,772 (0.03%) (542nd) |
|
52w High $0.035 |
52w Low $0.012 |
P/E 11.29 |
EPS -0.06 |
UBI released this announcement to the ASX on 11 April 2023, 8:15. The announcement is not marked as price sensitive, and is 38 page(s) in length and 1.03MB in size.
You can view all announcements from UBI and see how they appear on a price chart on the announcements page.
At the date of this announcement, UBI was 0.029% short sold according to ASIC data. It was ranked the 544th most shorted stock on the ASX. It is now ranked as the 542nd most shorted stock on the ASX with 0.030% of total shares short sold as of the latest reported data (05 October 2023).
| Other Recent Announcements from UBI | |
|---|---|
| Results of 2023 Annual General meeting | 22 May 2023, 12:14 |
| CEO's AGM address to Securityholders | 22 May 2023, 8:33 |
| Q1 2023 Results | 11 May 2023, 15:41 |
| Notice of Meeting/Proxy Statement | 11 April 2023, 8:15 |
| UBI submits Xprecia Prime 510K Application to FDA | 24 March 2023, 10:45 |
| Appendix 3Y - Graham McLean | 16 March 2023, 8:40 |
| FY2022 Corporate Governance Statement & Appendix 4G | 14 March 2023, 11:43 |
You must be logged in to post a reply.
Universal Biosensors, Inc 